Polifarmácia em idosos: riscos, consequências clínicas e a inserção do estudante de medicina na prática da prescrição segura
Revista ft · 25.05.2026 · 30 (158) · 01-38
DOI: 10.69849/e5eg1n37 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista ft, online erschienen am 25.05.2026. Verfasst von Hélio da Silva Freitas Queiroz Neto und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Polypharmacy is an increasingly prevalent phenomenon in the context of population aging, being directly associated with multimorbidity and the clinical complexity of older adults. This study aimed to analyze the impacts of polypharmacy in the elderly population, with emphasis on clinical outcomes, associated risks, and therapeutic management strategies, as well as to critically discuss the integration of medical students into safe prescribing practices. This is an integrative literature review conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The bibliographic search was performed in the PubMed/MEDLINE, Scopus, Web of Science, Embase, and SciELO databases, including studies published between 2014 and 2025 in English, Portuguese, and Spanish. At the end of the selection process, 40 studies were included in the integrative synthesis. The results showed that polypharmacy is associated with a higher incidence of adverse drug events, falls, hospitalizations, functional impairment, and reduced treatment adherence. In addition, physiological changes related to aging increase pharmacological vulnerability, raising the risk of drug interactions and toxicity. Key strategies for managing polypharmacy include systematic medication review, the use of tools such as the Beers Criteria and STOPP/START, as well as deprescribing practices. A multidisciplinary approach proved essential for promoting rational drug use and improving patients’ quality of life. It is concluded that polypharmacy represents a significant challenge for clinical practice and healthcare systems, requiring integrated, individualized, and evidence-based approaches.
Zitieren
APA
Neto, H. D. S. F. Q., & Queiroz, H. L. (2026). Polifarmácia em idosos: riscos, consequências clínicas e a inserção do estudante de medicina na prática da prescrição segura. Revista ft, 30(158), 01-38. https://doi.org/10.69849/e5eg1n37
Vancouver
Neto HDSFQ, Queiroz HL. Polifarmácia em idosos: riscos, consequências clínicas e a inserção do estudante de medicina na prática da prescrição segura. Revista ft. 2026;30(158):01-38. doi:10.69849/e5eg1n37
BibTeX
@article{Neto2026,
author = {Neto, Hélio da Silva Freitas Queiroz and Queiroz, Hélio Lemes},
title = {Polifarmácia em idosos: riscos, consequências clínicas e a inserção do estudante de medicina na prática da prescrição segura},
journal = {Revista ft},
year = {2026},
volume = {30},
number = {158},
pages = {01--38},
doi = {10.69849/e5eg1n37}
}
EUVIMED